97503 ⎘
Preparation of polysaccharides not provided for in groups - ; Derivatives thereof; Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof; Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Sub-classes:CHEMICALLY MODIFIED HEPARIN
#2CHEMICALLY MODIFIED HEPARIN
#3RECOMBINANT HEPARIN-LIKE SUBSTANCE AND METHOD FOR PRODUCING THE SAME
#4ADHESIVE CELL TISSUE GELS
#5HEPARIN AND MIXTURES OF NATIVE PROTEINS AND PEPTIDES FROM WASTE TISSUE OF SLAUGHTERED ANIMALS
#6METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS
#7METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS
#8Dendritic Macroporous Hydrogels Prepared By Crystal Templating
#9MATRICES COMPRISING A MODIFIED POLYSACCHARIDE
#10HEPARIN FROM MODIFIED MST CELLS AND METHODS OF MAKING AND USING
#11COMPOSITIONS AND METHODS FOR TREATING A DISORDER OR DEFECT IN SOFT TISSUE
#12PREPARATION AND/OR FORMULATION OF PROTEINS CROSS-LINKED WITH POLYSACCHARIDES
#13SHORT-ACTING HEPARIN-BASED ANTICOAGULANT COMPOUNDS AND METHODS
#14CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING
#15Dendritic macroporous hydrogels prepared by crystal templating
#16METHODS FOR SYNTHESIZING ANTICOAGULANT POLYSACCHARIDES
#17FISH SWIM BLADDER-DERIVED HEPARIN-LIKE MUCOPOLYSACCHARIDE AND METHODS OF MAKING AND USING THE SAME
#18BIOSYNTHETIC HEPARIN
#19Method for obtaining low molecular weight heparins and low molecular weight heparins obtained therefrom
#202-O-sulfation enzyme mutant and 3-O-sulfation enzyme mutant, and method for using same
#21SYNTHESIS OF CROSS-LINKED SPHERICAL POLYCATIONIC BEAD ADSORBENTS FOR HEPARIN RECOVERY
#22PROCESS FOR DIRECT SULFATION OF POLYSACCHARIDES IN AN ECOLOGICALLY ACCEPTABLE SOLVENT
#23Methods for synthesizing anticoagulant polysaccharides
#24NOVEL MIMETICS OF HEPARIN OLIGOSACCHARIDES
#25METHOD FOR PRODUCING HEPARIN-LIKE SUBSTANCE, RECOMBINANT CELL, AND METHOD FOR PRODUCING THE SAME
#26Compositions and Methods for Treating a Disorder or Defect in Soft Tissue
#27Rapid testing mechanism and method for respiratory viral pathogens
#28Method for Obtaining Low Molecular Weight Heparins by Tangential Flow Filtration
#29INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#30NOVEL DRUG DELIVERY CONJUGATED MOIETY FOR ORAL ADMINISTRATION OF DRUG UNSUITABLE FOR ORAL ADMINISTRATION AND PREPARATION METHOD THEREOF
#31Methods for synthesizing anticoagulant polysaccharides
#32PREPARATION AND/OR FORMULATION OF PROTEINS CROSS-LINKED WITH POLYSACCHARIDES
#33PRODUCTION OF BIOMEDICAL COMPOUNDS BY ENRICHMENT CULTURES OF MICROORGANISMS
#34Matrices comprising a modified polysaccharide
#35Rapid testing mechanism and method for respiratory viral pathogens
#36DERIVATIVES OF N-DESULFATED GLYCOSAMINOGLYCANS AND USE AS DRUGS
#37Dendritic macroporous hydrogels prepared by crystal templating
#38SULFUR-CONTAINING GLYCANS AND POLYSACCHARIDES AND METHODS OF CHEMOENZYMATIC SYNTHESIS THEREOF
#39Degradable thiol-ene polymers and methods of making thereof
#40Short-acting heparin-based anticoagulant compounds and methods
#41Self-repairing polyurethane networks
#42Derivatives of N-desulfated glycosaminoglycans and use as drugs
#43Cellular glycosaminoglycan compositions and methods of making and using
#44INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#45Methods of Releasing Glycans from Peptides and Other Conjugates
#46Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit
#47Preparation and/or formulation of proteins cross-linked with polysaccharides
#48Derivatives of N-desulfated glycosaminoglycans and use as drugs
#49Expedient synthesis of core disaccharide building blocks from natural polysaccharides for heparan sulfate oligosaccharide assembly
#50Carboxylated derivatives of glycosaminoglycans and use as drugs
#512-O-sulfation enzyme mutant and 3-O-sulfation enzyme mutant, and method for using same
#52Carboxylated derivatives of glycosaminoglycans and use as drugs
#53Dendritic macroporous hydrogels prepared by crystal templating
#54Method for producing sugar having sulfate group and/or phosphate group
#55METHOD AND MATERIAL FOR DIFFERENTIATED SEQUESTRATION OF SUBSTANCES OF DIFFERENT SUBSTANCE GROUPS WITH THE AID OF HYDROGELS CONTAINING SULPHATED OR SULPHONATED COMPONENTS
#56IN VITRO HEPARIN AND HEPARAN SULFATE COMPOSITIONS AND METHODS OF MAKING AND USING
#57Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery
#58Solid state nanopores aided by machine learning for identification and quantification of heparins and glycosaminoglycans
#59Apparatus and method for preserving mucosa
#60Biosynthetic heparin
#61Compositions and Methods for Treating a Disorder or Defect in Soft Tissue
#62HEPARAN SULPHATE
#63Hydrogel microparticle scaffold with gradients of degradability and methods thereof
#64Adhesive cell tissue gels
#65SHALE SWELLING INHIBITORS
#66Isolation and Identification of Glycosaminoglycans
#67Light-activated preparation of hydrogels
#68Matrices comprising a modified polysaccharide
#69Self-Repairing Polyurethane Networks
#70Heparan sulfate having high 3-O-sulfation rate in glucosamine residues
#71Process for depleting epoxide species in crosslinked polysaccharide gel compositions and compositions obtained thereby
#72PDGF-B /PDGF-BB binding variants of heparan sulfates
#73Heparosan-producing bacterium and heparosan manufacturing method
#74PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS
#75Inhibitors of PCSK9 for treatment of lipoprotein metabolism disorders
#76Dendritic macroporous hydrogels prepared by crystal templating
#77Glycosaminoglycan esters, processes for their preparation and their use in formulations for ophthalmic use
#78Method for sulfating glycosaminoglycan
#79Hydrogel microparticle scaffold with gradients of degradability and methods thereof
#80Method for production of heparin and heparan sulfate
#81Degradable thiol-ene polymers and methods of making thereof
#82Cosmetic process for attenuating wrinkles
#83Cosmetic use of heparan sulphate
#84Heparan sulphates for use in repair and/or regeneration of skin
#85Carboxylated Derivatives of Glucosaminoglycans and Use as Drugs
#86Preparation and/or formulation of proteins cross-linked with polysaccharides
#87APPARATUS AND METHOD FOR PRESERVING MUCOSA
#88Heparosan-Based Biomaterials and Coatings and Methods of Production and Use Thereof
#89Conjugate of a fragment of a cellular wall of a bacterium and a mucopolysaccharidic carrier, and uses in medicine thereof
#90Method for in vivo production of glycosaminoglycans
#91Glycosaminoglycans
#92Heparan sulphates
#93APPARATUS AND METHOD FOR PRESERVING MUCOSA
#94Glycosaminoglycans
#95POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS
#96Carboxylated derivatives of glycosaminoglycans and use as drugs
#97Self-repairing polyurethane networks
#98Dendritic macroporous hydrogels prepared by crystal templating
#99Derivatives of N-desulfated glycosaminoglycans and use as drugs
#100Compositions and method for anti-sickling of red blood cells in sickle cell disease
#101HEPARAN SULPHATE
#102NANOSENSOR FOR DETECTING THE ACTIVITY OF GLYCOSAMINOGLYCAN-CLEAVING ENZYMES AND USES THEREOF
#103Heparosan-producing bacterium and heparosan manufacturing method
#104Processes for the production of chemically-modified heparins
#105Reversible heparin molecules and methods of making and using the same
#106Heparosan-glucuronic acid-5-epimerase, and method for producing polysaccharide using same
#107Heparan sulphates
#108Heparan sulfate synthesis
#109CONJUGATE OF A FRAGMENT OF A CELLULAR WALL OF A BACTERIUM AND A MUCOPOLYSACCHARIDIC CARRIER, AND USES IN MEDICINE THEREOF
#110Shale swelling inhibitors
#111Photoactive bioadhesive compositions
#112Preparation of new intermediate of heparin pentasaccharide and preparation method thereof
#113Method for preparing porous scaffold for tissue engineering
#114High purity heparin and production method therefor
#115Low anticoagulant heparins
#116Analytical method for detecting sulfated oligosaccharides
#117Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
#118Use of chemically modified heparin derivates in sickle cell disease
#119RAPID TWO-STEP SYNTHESIS OF ANTI-COAGULANTS
#120Process for the preparation of highly O-sulfated, epimerized derivatives of K5 polysacchride and intermediates therein
#121Dendritic macroporous hydrogels prepared by crystal templating
#122Chemoenzymatic synthesis of heparin and heparan sulfate analogs
#123PREVENTION AND/OR TREATMENT OF CANCER AND/OR CANCER METASTASIS
#124Matrices comprising modified polysaccharides and modified polysaccharides
#125Self-repairing cyclic oxide-substituted chitosan polyurethane networks
#126Evaluating heparin preparations
#127Antiinfective composition
#128Oligosaccharide compounds
#129Polysaccharides comprising two antithrombin III-binding sites, preparation thereof and use thereof as antithrombotic medicaments
#130Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#131Capillary electrophoresis method for fine structural analysis of enoxaparin sodium
#132Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins
#133Preparation and/or formulation of proteins cross-linked with polysaccharides
#134METHODS OF CRYODESICCATING A BROTH COMPRISING A BIOPOLYMER OF AN EXOPOLYSACCHARIDE
#135Implantation material comprising biocompatible polymer
#136High purity heparin and production method therefor
#137Anticoagulant-conjugated carbon nanocapsule, antithrombotic agent containing thereof
#138Method of modulating release of biomolecules having heparin-binding affinity
#139Compositions and Methods for Treating a Disorder or Defect in Soft Tissue
#140Glycosaminoglycans
#141Polysaccharide-grafted polyethylenimine as a gene carrier
#142Silyl-derivatives of polysaccharides
#143Methods for analyzing a heparin sample
#144ADHESIVE CELL TISSUE GELS
#145PROCESS FOR THE PREPARATION OF HIGHLY O-SULFATED EPIMERIZED DERIVATIVES OF K5 POLYSACCHARIDE AND INTERMEDIATES THEREIN
#146Isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair
#147FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof
#148FGF receptor-activating N-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
#1496-0-SULFATED POLYSACCHARIDES AND METHODS OF PREPARATION THEREOF
#150Modified macromolecules and associated methods of synthesis and use
#151HEPARAN SULFATE SYNTHESIS
#152Process for the synthesis of conjugates of glycosaminoglycanes (GAG) with biologically active molecules, polymeric conjugates and relative uses thereof
#153Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
#154SULFATED POLYSACCHARIDES HAVING ANTIPLASMODIAL ACTIVITY AND METHODS AND PRODUCTS FOR IDENTIFYING ANTIPLASMODIAL ACTIVITY
#155Heparan sulphate
#156Bioactive hydrogel
#157MODIFIED HEPARINASE III AND METHODS OF SEQUENCING THEREWITH
#158Polysaccharides with antithrombotic activity, including a covalent bond and an amino chain
#159PROCESS FOR PRODUCING GLYCOSAMINOGLYCANS
#160Heparin coatings
#161Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
#162Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
#163Biomaterial based on Wharton's jelly from the human umbilical cord
#164HEXADECASACCHARIDES WITH ANTITHROMBOTIC ACTIVITY, INCLUDING A COVALENT BOND AND AN AMINO CHAIN
#165Method for treating or inhibiting the formation of adhesions following surgery or injury
#166OLIGOSACCHARIDE COMPOUNDS FOR USE IN MOBILISING STEM CELLS
#167Heparan sulphate which binds BMP2
#168COMPOSITIONS AND SYSTEMS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE
#169Isolation and Identification of Glycosaminoglycans
#170COMPOSITIONS OF POLYSACCHARIDES DERIVED FROM HEPARIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#171SEPARATION OF POLYSACCHARIDES BY CHARGE DENSITY GRADIENT
#172Crosslinked polysaccharide sponge
#173Selectively-Releasable Adhesives That Include A Glycosominoglycan
#174METHODS OF MAKING LOW MOLECULAR WEIGHT HEPARIN COMPOSITIONS
#175Artificial Organelle On A Digital Microfluidic Chip Used To Redesign The Biological Activities of Heparan Sulfate
#176Method for finger-printing heparins
#177Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
#178APPARATUS AND METHOD FOR PRESERVING MUCOSA
#179Compounds and method for coating surfaces in a hemocompatible manner
#180Dendritic macroporous hydrogels prepared by crystal templating
#181MODIFIED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF
#182Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#183Production Of L-Iduronate Containing Polysaccharides
#184Silver nanoparticles as anti-microbial
#185Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics
#186Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
#187Synthesis of lipoamide-grafted high molecular compound and method therefor
#188Self-repairing cyclic oxide-substituted chitosan polyurethane networks
#189Polysaccharide derivatives of lipoic acid, and their preparation and use as skin cosmetics and medical devices
#190Adhesive tissue repair patch and collagen sheets
#191Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery
#192Method for preparing porous scaffold for tissue engineering
#193METHOD OF CONTROLLING THE CONTENT OF SELECTED COMPONENT(S) FROM POLYMER(S) USING MOLECULAR SIEVE(S)
#194Thiol-modified macromolecule derivatives and cross-linked materials thereof
#195LOW MOLECULAR WEIGHT HEPARINS INCLUDING AT LEAST ONE COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE, METHOD FOR MAKING SAME AND USE THEREOF
#196HEPARINS INCLUDING AT LEAST ONE COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE, METHOD FOR PREPARING SAME AND USE THEREOF
#197Methods for analyzing or processing a heparin sample
#198Cross-linked polysaccharide gels
#199Process for preparing uronic acid oligosaccharides by extrusion
#200Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
#201Heparin prodrugs and drug delivery stents formed therefrom
#202Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
#203Heparin prodrugs and drug delivery stents formed therefrom
#204TREATMENT AND PREVENTION OF ABNORMAL CELLULAR PROLIFERATION
#205Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
#206Heparin conjugates and methods
#207Production of L-iduronate containing polysaccharides
#208Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and a liquid embolic agent
#209Method for determination of N-deacetylase/N-sulfotransferase activity
#210POLYMER-METAL CHELATOR CONJUGATES AND USES THEREOF
#211Modified heparinase III and methods of sequencing therewith
#212Novel Heparin Alternative Material and Method for Producing the Same
#213Aneurysm occlusion device containing bioactive and biocompatible copolymer shell and biocompatible metallic frame member
#214ENZYMATIC SYNTHESIS OF SULFATED POLYSACCHARIDES WITHOUT IDURONIC ACID RESIDUES
#215Process for the preparation of N-acyl-(epi)K5-amine-O-sulfate-derivatives and products thus obtained
#216Bioactive and biocompatible polyurethane-buthanediol-glycosaminoglycan salt copolymers
#217Composition forstimulating bone growth and differentiation and method for isolating same
#218Preparation and application of heparin silver
#219USE OF HEPARINOID DERIVATIVES FOR THE TREATMENT AND DIAGNOSIS OF DISORDERS WHICH CAN BE TREATED WITH HEPARINOIDS
#220Heparosan-based biomaterials and coatings and methods of production and use thereof
#221Methods for synthesizing polysaccharides
#222Process for isolating biomaterial from tissue and an isolated biomaterial extract prepared therefrom
#223Highly sulfated derivatives of K5 polysaccharide and their preparation
#224Lubricious biopolymeric network compositions and methods of making same
#225Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
#226Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
#227Crosslinked polysaccharide sponge
#228Crosslinked polysaccharide sponge
#229THIOLATED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF
#230Modified macromolescules and associated methods of synthesis and use
#231Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
#232Methods for evaluating the quality of a heparin sample
#233Amphiphilic heparin derivative formed by coupling a heparin with a bile acid
#234Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same
#235Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome
#236Use of lipid conjugates in the treatment of disease
#237Methods and producing low molecular weight heparin
#238Cross-linked polysacharide and protein matrices and methods for their preparation
#239Polysaccharide derivatives with high antithrombotic activity in plasma
#240Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
#241Hgf production accelerator containing heparin-like oligosaccharide
#242Method of controlling the content of selected component(s) from polymer(s) using molecular sieve(s)
#243Saccharide libraries
#244Process for induction of intramolecular migration of sulfates, phosphates, and other oxyanions
#245Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
#246Compositions of low molecular weight heparin produced with modified heparinase III
#247Methods for preparing low molecular weight heparin with modified heparinase III
#248Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
#249Rapid two-step synthesis of anti-coagulants
#250Heparinase III and methods of specifically cleaving therewith
#251Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide
#252Methods and products related to evaluating the quality of a polysaccharide
#253Heparin prodrugs and drug delivery stents formed therefrom
#254Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
#255Composition for stimulating bone growth and differentiation and method for isolating same
#256Treatment and prevention of abnormal cellular proliferation
#257Process for the preparation of esters of heparin
#258Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
#259Methods for synthesis of sulfated saccharides
#260Low molecular weight oversulfated polysaccharide
#261Process for the physical depolymerization of glycosaminogylcanes and products obtained thereform
#262Low molecular weight heparin salt with triethanolamine useful as therapeutic-antitrombotic agent of local delivery, procedures for preparing them, process for elimination of hygroscopicity of heparin salt, pharmaceutical compositions for local use in antithrombotic therapy and uses therein
#263O-sulphated bacterial polysaccharides and their use
#2646-O-sulfated N-acetylheparosan and hematopoietic stem cell growth auxiliary agent
#265Heparinase III HLGAG fragments and uses thereof
#266Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
#267Solid- and solution-phase synthesis of heparin and other glycosaminoglycans
#268Compounds and method for coating surfaces in a haemocompatibe manner
#269Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
#270Crosslinked polymer compositions
#271Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
#272Saccharide sulfation methods
#273Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
#274Construction and use of synthetic constructs encoding syndecan
#275Adhesive tissue repair patch
#276Method for preparing heparin from mast cell cultures
#277Method for preparing a biocompatible crosslinked matrix and matrix provided thereby
#278Biocompatible crosslinked composition
#279Polysaccharides and methods and intermediates useful for their preparation
#280Highly sulfated derivatives of K5 polysaccharide and their preparation
#281Method for extracting unfractionated heparin from camel intestinal mucosa